BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18717978)

  • 1. UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes.
    Adler AI
    Diabet Med; 2008 Aug; 25 Suppl 2():41-6. PubMed ID: 18717978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).
    Lee JD; Morrissey JR; Patel V;
    Curr Med Res Opin; 2004 May; 20(5):765-72. PubMed ID: 15140344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
    Adler AI; Levy JC; Matthews DR; Stratton IM; Hines G; Holman RR
    Diabet Med; 2005 Mar; 22(3):306-11. PubMed ID: 15717879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for tighter control of cardiovascular risk factors in diabetic patients.
    Viberti G
    J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain.
    Lahoz-Rallo B; Blanco-Gonzalez M; Casas-Ciria I; Marín-Andrade JA; Mendez-Segovia JC; Moratalla-Rodriguez G; Quintero-Dominguez R; Ramirez-Raya M; Guerrero-Pinedo MJ; Aguilar-Diosdado M
    Diabetes Res Clin Pract; 2007 Jun; 76(3):436-44. PubMed ID: 17064808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
    Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
    Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
    Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
    Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the start time of statin therapy for patients with diabetes.
    Denton BT; Kurt M; Shah ND; Bryant SC; Smith SA
    Med Decis Making; 2009; 29(3):351-67. PubMed ID: 19429836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
    Clarke PM; Hayes AJ; Glasziou PG; Scott R; Simes J; Keech AC
    Med Care; 2009 Jan; 47(1):61-8. PubMed ID: 19106732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and cardiovascular risk of new cases of type 2 diabetes in Otago, New Zealand, 1998-2004.
    Coppell K; Williams S; Anderson K; Lamb C; Mann J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):396-401. PubMed ID: 18990463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress.
    Mourad JJ; Le Jeune S
    J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study.
    Soriguer F; Morcillo S; Hernando V; Valdés S; Ruiz de Adana MS; Olveira G; Fuentes EG; González I; Tapia MJ; Esteva I; Rojo-Martínez G
    Menopause; 2009; 16(4):817-21. PubMed ID: 19387417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassessment of cardiovascular risk in diabetes.
    Jaffe JR; Nag SS; Landsman PB; Alexander CM
    Curr Opin Lipidol; 2006 Dec; 17(6):644-52. PubMed ID: 17095909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smoking and other risk factors of cardiovascular diseases, connected with arteriosclerosis among youth].
    Chmiel-Połeć Z; Cybulska I
    Przegl Lek; 2008; 65(10):437-45. PubMed ID: 19189518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.